Navigation Links
Combating a crisis: Global burden of preterm birth can be reduced if critical actions are taken
Date:11/6/2012

New surveys of researchers and funders reveal a lack of consensus regarding researching and developing interventions to prevent prematurity and stillbirth, according to an article published in the American Journal of Obstetrics and Gynecology ahead of World Prematurity Day on November 17.

Authored by Michael G. Gravett, MD, scientific director of the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS), an initiative of Seattle Children's, and Craig E. Rubens, MD, PhD, executive director of GAPPS, the article outlines significant opportunities to enhance research into pregnancy complications and develop solutions to prevent prematurity and stillbirth, which combined take the lives of 4 million babies every year.

"One of the main observations from the technical team was that current research funding is fragmented and uncoordinated, lacking central leadership," the authors write in A framework for strategic investments in research to reduce the global burden of preterm birth. "Funders do not understand where the field is going."

Gravett and Rubens surveyed researchers and funders and found that both parties are equally uncertain about research and development projects that need to be undertaken, and many funders are hard-pressed to support research on the complex problems of pregnancy and childbirth given competing priorities. This lack of consensus provides an opportunity to engage with funders and researchers to recognize the importance of understanding healthy pregnancies and the consequences of adverse pregnancy outcomes.

The article proposes that a strategic alliance of funders, researchers, nongovernmental organizations, the private sector, and others could organize a set of grand challenges centered on pregnancy and childbirth that could yield a substantial improvement in the development and delivery of new and much more effective interventions, even in low-resource settings.

The authors note: "Pregnancy remains one of the least explored aspects of human biology, creating a tremendous opportunity. Long-term funding commitments for research could advance discovery science and the development of interventions targeted at pregnancy and early life and impact maternal and newborn health around the world."

Preterm birth and stillbirth are among the greatest health burdens associated with pregnancy and childbirth. Fifteen million babies are born preterm each year, causing about 1 million deaths annually and lifelong problems for many survivors; 3 million stillbirths also occur annually. Worldwide, the number of women and children who die during pregnancy and childbirth exceeds the total number of births in the United States. Even if all current interventions were universally applied, the authors estimate that the preterm birthrate would drop by less than 20 percent.

Based on their interviews, the authors compiled a set of recommendations that could greatly improve the visibility of research on pregnancy, childbirth, and early life, and mobilize funders to increase investments leading to the discovery, development, and delivery of low-cost and high-impact interventions to prevent preterm birth and stillbirth.

Toward making every pregnancy a healthy pregnancy:

  • Emphasize that healthy outcomes in pregnancy benefit everyone, directly and indirectly

  • Raise awareness of personal and public burden of prematurity, stillbirth, and other pregnancy and early life problems

  • Establish strategic alliance of funders, researchers, and other stakeholders in areas of pregnancy, childbirth, and early life

  • Identify commonalities among funding organizations to develop a coordinated research and intervention agenda

  • Identify and promote research opportunities in areas of pregnancy, childbirth, and early life that can attract investigators

  • Engage new investigators from multiple disciplines

  • Utilize descriptive sciences and economic modeling to establish true costs and burdens of disease and assess impact of costs of current or future interventions

  • Establish collaborations and promote research within high-burden, low-resource countries

Key considerations in developing a framework for a global approach to reduce preterm birth and stillbirth:

  • Develop and adopt clear and consistent definitions and classification criteria

  • Longitudinally characterize determinants of healthy continuum pregnancy and pathologic perturbations

  • Recognize preterm birth and stillbirth as multifactorial, complex endpoints

  • Develop predictive biomarkers and interventions that are pathway-specific for varied causes of preterm birth and stillbirth

  • Develop infrastructure to support population-specific research and intervention in high-burden, low-resource settings

  • Link discovery science to intervention development and implementation science


'/>"/>
Contact: Casey Calamusa
Casey.Calamusa@seattlechildrens.org
206-884-1014
Seattle Children's
Source:Eurekalert

Related medicine news :

1. Plastic and Reconstructive Surgery Journal announces global expansion initiatives
2. $20 million gift launches new hub for global health at UCSF
3. Cardiovascular disease community calls for tougher targets to curb global risk
4. 2012 Pacific Global Health Conference
5. NTU and University of Warwick boost brainpower in global neuroscience research
6. Local talent: Global impact public invited to meet world-class researchers at Queens
7. Funding for neglected global diseases research at UBC exceeds $20 million
8. Premier global health journal, The Lancet, releases series on universal health coverage
9. Global platelet reactivity identifies high risk ACS patients
10. Global platelet reactivity and high risk ACS patients
11. Global study suggests need for strategies to combat unhealthy lifestyles among the poor and the rich
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... herbal-based and non-steroidal skincare products, was awarded as winners of American Dreams & ... This competition was hosted jointly by HSN and Good Housekeeping. , Steven ...
(Date:3/23/2017)... VA (PRWEB) , ... March ... ... Evaluation Reports: Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. ... 3:00 p.m. ET, http://www.fdanews.com/mdclineval                  , How will the new EU ...
(Date:3/23/2017)... ... March 23, 2017 , ... GeBBS Healthcare Solutions unveils the ... 21st annual Compliance Institute on March 26-28 in National Harbor, Maryland. ... chart types with a comprehensive set of features including built-in workflow, interactive audit ...
(Date:3/23/2017)... ... ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous power ... Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures which ... new book presents actual events in the life of her family, which validate her ...
(Date:3/23/2017)... ... March 23, 2017 , ... “My Journey Through Heaven”: the true-life ... infinitely more profound faith of God’s promise of Heaven for His people. “My Journey ... each day with his wife, three children and six grandchildren living and doing for ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") ... is pleased to announce that its majority-owned subsidiary, ... U.S. Food and Drug Administration (FDA) for the ... tablets in the 12.5 mg and 25 mg ... equivalent of the branded product Xenazine ® ...
(Date:3/23/2017)... , March 23, 2017 ReNeuron ... its CTX cells in chronic stroke patients, despite not meeting ... primary outcome measure, the Action Research Arm Test (ARAT). As ... to a pivotal controlled clinical study in 2017. Beyond CTX, ... (RP) trial in 2017 and Phase I data from its ...
(Date:3/23/2017)... 2017 The Board of Directors of NeuroVive ... Meeting, which is to take place on Thursday, April 27, 2017, ... Lund, Sweden . ... Please see the attached notification, which is being announced within ... NeuroVive Pharmaceutical AB (Publ) The Board Of Directors About ...
Breaking Medicine Technology: